Handwriting Analysis in Movement Disorders.
1 other identifier
observational
100
1 country
1
Brief Summary
Movement disorders are a group of neurological conditions that cause problems with movement, either in the form of excessive, reduced, or slow movements. Some commonly known movement disorders include Parkinson disease, dystonia, ataxia, and Tourette syndrome. Multiple movement disorders have unique handwriting characteristics that can be measured using an inkless pen and a digitalized tablet. Handwriting is a complex skill that requires a combination of cognition, motor planning, and visuomotor integration. Handwriting deteriorates in patients with neurodegenerative diseases. This study aims to discern variations in the kinematics (movement patterns) involved in handwriting between individuals with movement disorders and healthy controls. Participants will be invited to carry out a series of handwriting tasks. The pen motions will be captured using an inkless pen and a digitizing tablet linked to a laptop. The entire set of tasks is designed to be completed within 30 minutes. The data will then be collected, processed, and analyzed utilizing a handwriting analysis software.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2024
CompletedFirst Posted
Study publicly available on registry
May 31, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2030
January 24, 2025
January 1, 2025
4.5 years
May 6, 2024
January 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Primary handwriting kinematic parameter (velocity)
Average absolute vertical velocity (cm/s)
Day 1
Secondary Outcomes (3)
Secondary handwriting kinematic parameter (acceleration)
Day 1
Secondary handwriting kinematic parameter (duration)
Day 1
Pen pressure
Day 1
Study Arms (2)
Cases
Diagnosed with a movement disorder
Control
Healthy controls
Eligibility Criteria
Movement disorder patients will be recruited from the London Movement Disorder Clinic.
You may qualify if:
- (1) Diagnosed with a movement disorder.
You may not qualify if:
- Action tremor or weakness in the dominant hand interfering with writing task.
- Unable to write or understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aditya Murgai
London, Ontario, N6A5A5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor in Neurology
Study Record Dates
First Submitted
May 6, 2024
First Posted
May 31, 2024
Study Start
January 1, 2025
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
July 1, 2030
Last Updated
January 24, 2025
Record last verified: 2025-01